Hospira To Pay $60M To Settle Shareholder Class Action

Law360, New York (March 28, 2014, 7:52 PM EDT) -- Global pharmaceutical company Hospira Inc. agreed to pay $60 million on Thursday to settle a class action lawsuit accusing it of violating securities laws by providing misleading positive statements that artificially inflated share prices despite problems at the company's manufacturing plant.

The lead plaintiffs in the class action moved for court approval of the settlement in Illinois federal court Thursday after coming to an agreement with Hospira following negotiations before a mediator. The agreement could put an end to the litigation that has been ongoing since 2011.

"The settlement is the result of well-informed and extensive arm's-length negotiations between and among highly experienced...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!